Role of miRNA signalling in the pathogenesis of MASLD

Area of Science:

• Molecular Biology
• Hepatology
• RNA Therapeutics

Background:

• Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing health concern.
• MicroRNAs (miRNAs) are implicated in MASLD pathogenesis, influencing its progression.
• miRNAs mediate communication within and to the liver, impacting disease development.

Purpose of the Study:

• To systematically review the roles of miRNA-mediated communication in MASLD.
• To evaluate current miRNA-targeting therapeutic strategies for MASLD.

Main Methods:

• Literature review of studies on miRNAs in MASLD.
• Analysis of miRNA roles in intrahepatic and extrahepatic communication.
• Evaluation of miRNA-based therapeutic approaches.

Main Results:

• miRNAs can promote or inhibit the transition from hepatic steatosis to more severe liver conditions.
• Intercellular communication via miRNAs is a key mechanism in MASLD progression.
• miRNAs offer advantages over conventional RNA therapeutics for MASLD.

Conclusions:

• miRNAs are critical regulators in MASLD development and progression.
• Targeting miRNAs presents a promising therapeutic avenue for MASLD.
• Further research into miRNA-based therapies is warranted for effective MASLD management.